Hepatitis B Infection in Vanuatu: Age of Acquisition of Infection and Possible Routes of Transmission

Abstract

Seroepidemiological studies of hepatitis B were carried out on diverse groups of children (477) and adults (629) from the Pacific Island country of Vanuatu. In children under 14 years, prevalences of HBsAg and of all markers were 6% and 53.3% respectively; in adults 20 years the prevalences were 15% and 70%. Age specific prevalence of hepatitis B infection (all markers) was low in infancy (< 1 year) but rose sharply afterwards, suggesting that the main mechanism of transmission was horizontal spread. This finding is consistent with other developing country studies from the Pacific Islands and elsewhere. In view of the main ages and mechanisms of transmission of hepatitis B in children in developing countries and the need for simple and inexpensive immunisation strategies in this context, it is recommended that mass vaccination of all infants with hepatitis B vaccine be undertaken in hyperendemic areas.

Keywords

hepatitis B hepatitis B antigen hepatitis B antibody Vanuatu Pacific Islands children age of acquisition of infection immunisation strategies

Get full access to this article

View all access options for this article.

References

1. Whittle HC , McLachlan K , Bradley AK et al.: Hepatitis B virus infection in two Gambian villages. The Lancet 1983; 1: 1203–6.

2. Leitchner AM , Leclair J , Goldman DA et al.: Horizontal, nonparenteral spread of hepatitis B among children. Annals of Internal Medicine 1981; 94: 346–9.

3. Kashiwagi S , Hayashi J , Ikematsu H et al.: Transmission of hepatitis B virus among siblings. American Journal of Epidemiology 1984; 120: 617–25.

4. Szmuness W , Prince AM , Hirsch RC et al.: Familial clustering of hepatitis B infection. The New England Journal of Medicine 1973; 289: 1162–6.

5. Stevens C , Beasley R , Tsue J et al.: Vertical transmission of hepatitis B antigen in Taiwan. The New England Journal of Medicine 1975; 292: 771–4.

6. Beasley RP , Hwang L-Y , Lin C-C et al.: Incidence of hepatitis B infections in pre-school children in Taiwan. Journal of Infectious Diseases 1982; 146: 198–204.

7. Okada K , Yamada T , Miyakawa Y et al.: Hepatitis B surface antigen in the serum of infants after delivery from asymptomatic carrier mothers. Journal of Pediatrics 1975; 87: 360–3.

8. World Health Organization . Prevention of Liver Cancer. Geneva: World Health Organization 1983 (WHO Tech. Rep. Ser. No. 691).

9. Beasley RP , Hwang L-Y , Lee GC-Y et al.: Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immunoglobulin and hepatitis B vaccine. The Lancet 1983; ii: 1099–102.

10.

10. Gust ID , Lehmann NI , Dimitrakakis M : A seroepidemiologic study of infection with HAV and HBV in five Pacific islands. American Journal of Epidemiology 1979; 110: 237–42.

11.

11. Wong DC , Purcell RH , Rosen I : Prevalence of antibody of hepatitis A and hepatitis B viruses in selected populations of the South Pacific. American Journal of Epidemiology 1979; 110: 227–36.

12.

12. Mazzur S , Bastiaans MJS , Nath N : Hepatits B virus (HBV) infection among children and adults in the Solomon islands. American Journal of Epidemiology 1981; 113: 510–19.

13.

13. Zhuang H , Coulepis AG , Zimmet P et al.: Seroepidemiology of infection with hepatitis B virus in Fiji. American Journal of Epidemiology 1982; 116: 608–16.

14.

14. Wainwright RB , McMahon BJ , Bender TR et al.: Prevalence of hepatitis B virus infection in Tonga: Identifying high-risk groups for immunisation with hepatitis B vaccine. International Journal of Epidemiology 1986; 15: 567–71.

15.

15. Lewis BD: Hepatitis B virus infection among native inhabitants of French Polynesia. A seroepidemiologic and genetic analysis. Doctor of medicine thesis, School of Medicine, Yale University, 1981.

16.

16. Taylor R, Whitmore J, Gust I et al.: Seroepidemiological studies of hepatitis B in Niue, 1980-1983. South Pacific Commission Technical Paper No. 182, Noumea, New Caledonia, 1984.

17.

17. Williamson HG , Gust ID , Dimitrakakis M et al.: Serological markers of hepatitis B infection in Niue children. The New Zealand Medical Journal 1985; 98: 275–7.

18.

18. Hawkes RA , Boughton CR , Ferguson V , Vale TG : The seroepidemiology of hepatitis in Papua New Gunea. II. A long-term study of hepatitis B. American Journal of Epidemiology 1981; 114: 563–73.

19.

19. Mazzur S , Jones N : Distribution of persistence of hepatitis B surface antigen and antibody in a Melanesian population. American Journal of Epidemiology 1977; 105: 107–12.

20.

20. Kuberski T , Le Gonidec G , Gust ID et al: Hepatitis B virus infections in Melanesians and Polynesians in New Caledonia. American Journal of Epidemiology 1981; 114: 355–61.

21.

21. Zhuang H , Coulepis AG , Gust I et al.: A cross sectional study of markers of hepatitis B infection in Niue. New Zealand Medical Journal 1983; 96: 330–2.

22.

22. Institut Pasteur: Hepatite B en Nouvelle-Caledonie. Annual report, Noumea, 1983.

23.

23. Ikahihifo T, Bender T, Taylor R et al.: Hepatitis B in women of the Marshall Islands: Planning a program for the prevention of transmission of infection to infants (in preparation).

24.

24. Taylor R, Fauran C, Berry P et al.: South Pacific Commission Infectious Diseases Project; Mele Village, Port Vila, Vanuatu: Report of the baseline survey. South Pacific Commission Technical Paper No. 184, Noumea, New Caledonia, 1984.

25.

25. Taylor R, Levy S, Bale M et al.: Vanuatu/WHO/SPC non-communicable disease survey 1985. South Pacific Commission Technical Paper No. 192, Noumea, New Caledonia, 1987.

26.

26. Armitage P : Statistical Methods in Medical Research. Oxford: Blackwell Scientific Publications, 1971.

27.

27. Botha JF , Ritchie MJJ , Dushieko GM et al.: Hepatitis B virus carrier state in black children in Ovamboland: role of perinatal and horizontal infection. The Lancet 1984; i: 1210–2.

28.

28. Prince AM , White T , Pollock N et al.: Epidemiology of hepatitis B infection in Liberian infants. Infection and Immunity 1981; 32: 675–80.

29.

29. Barin F , Perrin J , Chotard J et al.: Cross-sectional and longitudinal epidemiology of hepatitis B in Senegal. Progress in Medical Virology 1981; 27: 148–62.

30.

30. Beasley RP , Trepo C , Stevens CE et al.: The e antigen and vertical transmission of hepatitis B surface antigen. American Journal of Epidemiology 1977; 105: 94–8.

31.

31. Lee AKY , Ip HMP , Wong VCW : Mechanisms of maternal-fetal transmission of hepatitis B virus. The Journal of Infectious Diseases 1978; 138: 668–71.

32.

32. Heathcote J , Cameron CH , Dane DS : Hepatitis B antigen in saliva and semen. The Lancet 1974; i: 71–5.

33.

33. Villaregos VM , Visona KA , Gutierrez A , Rodriguez A : Role of saliva, urine and faeces in transmission of type B hepatitis. New England Journal of Medicine 1974; 291: 1375–8.

34.

34. Tibbs CJ : Hepatitis B, tropical ulcers, and immunisation strategy in Kiribati. British Medical Journal 1987; 294: 537–9.

35.

35. Milne A , Allwood GK , Moyes CD et al.: A seroepidemiological study of the prevalence of hepatitis B infections in a hyperendemic New Zealand community. International Journal of Epidemiology 1987; 16: 84–90.

36.

36 Tong MJ , Weiner JM , Ashcavai MW et al.: A comparative study of hepatitis B viral markers in the family members of Asian and non-Asian patients with hepatitis B surface antigen-positive hepatocellular carcimona and with chronic hepatitis B infection. Journal of Infectious Diseases 1979; 140: 506–12.

37.

37. Punyagupta S , Olson L , Harinasuta U et al.: The epidemiology of hepatitis B antigen in a high prevalence area. American Journal of Epidemiology 1973; 97: 349–54.

38.

38. Taylor R, Biumaiwai M, Gust I et al.: A seroepidemiological survey of hepatitis B amongst Fiji health care workers. South Pacific Commission Technical Paper No. 190. Noumea, New Caledonia, 985.

39.

39. Hepatitis Research Unit, Whakatane Hospital and South Pacific Commission: Report of the scientific meeting on control of hepatitis B infections in infants and children in high risk areas of the world. Whakatane, New Zealand, November 12-14, 1987. Noumea, New Caledonia, 1988.

40.

40. South Pacific Commission: Hepatitis B immunisation programme in the Pacific. Information Circular (Health) No. 112, Noumea, New Caledonia, 1988.

41.

41. Wong VCW , Ip HMH , Reesink HW et al.: Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBsAg by administration of hepatitis B vaccine and hepatitis B immunoglobulin. The Lancet 1985; i: 921–6.

42.

42. Maupas P , Chiron J-P , Barin F et al.: Efficacy of hepatitis B vaccine in prevention of early HBsAg carrier state in children. The Lancet 1981; i: 289–92.

43.

43. Maynard JE: Hepatitis B: strategy for control and prevention. World Health Organization, Japan: Report on the second task force meeting on hepatitis B, 1984.